2 results
Approved WMORecruiting
This study has been transitioned to CTIS with ID 2023-508101-24-00 check the CTIS register for the current data. The primary objective of the first randomized question (R1) open for allLBL patients (pts) of the core study cohort, is to evaluate…
Approved WMORecruitment stopped
To estimate the prothrombotic phenotype of patients with MM, on treatment with IMiD, using whole blood thrombin generation (WB-TG), platelet activation assays and PMC formation.